1.84
Repare Therapeutics Inc Azioni (RPTX) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
5.916
|
- | - | 1.073 | 52.40 |
|
|
24.02%
23.70
|
31.19 | 36.37 | 38.39 | 41.59 |
| Benefits Costs and Expenses |
24.47%
22.41
|
29.67 | 33.92 | 35.52 | 38.61 |
| Costs And Expenses |
24.02%
23.70
|
31.19 | 36.37 | 38.39 | 41.59 |
| Operating Income/Loss |
42.99%
-17.78
|
-31.19 | -36.37 | -37.32 | 10.82 |
| Nonoperating Income/Loss |
15.19%
1.284
|
1.514 | 2.451 | 2.871 | 2.975 |
| Income/Loss From Continuing Operations Before Tax |
44.41%
-16.50
|
-29.67 | -33.92 | -34.45 | 13.79 |
| Income Tax Expense/Benefit |
32.97%
0.248
|
0.37 | 0.485 | 0.326 | 0.629 |
| Income/Loss From Continuing Operations After Tax |
44.27%
-16.74
|
-30.04 | -34.41 | -34.77 | 13.16 |
|
|
44.27%
-16.74
|
-30.04 | -34.41 | -34.77 | 13.16 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.78%
42.92
|
42.59 | 42.45 | 42.45 | 42.23 |
| Diluted Average Shares |
0.78%
42.92
|
42.59 | 42.45 | 42.45 | 44.02 |
| Basic Earnings Per Share |
45.07%
-0.39
|
-0.71 | -0.81 | -0.82 | 0.31 |
| Diluted Earnings Per Share |
45.07%
-0.39
|
-0.71 | -0.81 | -0.82 | 0.30 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):